Manumycin A from a new Streptomyces strain induces endoplasmic reticulum stress-mediated cell death through specificity protein 1 signaling in human oral squamous cell carcinoma

International Journal of Oncology
Jung Jae ChoJung-Hyun Shim

Abstract

Manumycin A (Manu A) is a natural antibiotic produced by new Streptomyces strain, exhibiting antitumor and anticancer effects. However, the anticancer effects of Manu A on oral squamous cell carcinoma (OSCC) have not been reported. OSCC is an aggressive type of cancer because of its poor prognosis and low survival rate despite advanced medical treatment. We observed that Manu A reduced cell growth and Sp1 protein levels in OSCC cell lines (HN22 and HSC4) in a dose- and time-dependent manner. We also observed downregulation of Sp1 downstream target genes such as p27, p21, Mcl-1 and survivin. Moreover, nuclear staining with DAPI showed that Manu A was able to cause nuclear condensation and further fragmentation. Flow cytometry analyses using Annexin V and propiodium iodide supported Manu A-mediated apoptotic cell death of OSCC cells. Furthermore, Bcl-2 family such as mitochondrial pro‑apoptotic Bax, anti-apoptotic Bcl-xl and Bid were regulated by Manu A, triggering the mitochondrial apoptotic pathway. In conclusion, these results indicate that Manu A is a potential to treat human OSCC via cell apoptosis through the downregulation of Sp1.

References

Sep 1, 1994·European Journal of Cancer. Part B, Oral Oncology·T BundgaardJ Wildt
Jun 24, 1997·Proceedings of the National Academy of Sciences of the United States of America·S KharbandaD Kufe
Dec 31, 1997·Molecular and Cellular Biology·A KelekarC B Thompson
Nov 21, 2000·The Journal of Experimental Medicine·J A HeibeinR C Bleackley
Jan 5, 2002·The New England Journal of Medicine·A ForastiereD Sidransky
Jan 24, 2002·The Journal of the American Dental Association·S Silverman
Jul 9, 2002·British Journal of Haematology·Maria Antonia FrassanitoFranco Dammacco
Jan 28, 2003·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·J LissowskaS Franceschi
Jul 30, 2003·Journal of Dental Research·C TanakaH Tanzawa
Aug 9, 2003·Biochemical Pharmacology·Te-Hsiu LeeWen-Chun Hung
Aug 24, 2004·The Journal of Biological Chemistry·Hirohito Yamaguchi, Hong-Gang Wang
Feb 5, 2005·Annals of Diagnostic Pathology·Antonio G NetoGregory N Fuller
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Sep 5, 2007·Cancer Metastasis Reviews·Daisuke Sano, Jeffrey N Myers
May 15, 2009·PloS One·Uppoor G BhatAndrei L Gartel
Jul 22, 2009·International Journal of Cancer. Journal International Du Cancer·Suying Lu, Michael C Archer
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Feb 26, 2011·Journal of Medical Microbiology·Qingming Xiong, Yasuko Rikihisa
Jul 26, 2011·Periodontology 2000·Newell W JohnsonA A Hemantha K Amarasinghe
Aug 20, 2011·Expert Opinion on Investigational Drugs·Bridget A QuinnPaul B Fisher
Oct 26, 2011·Medicinal Chemistry·Umesh T SankpalRiyaz Basha
Sep 20, 2012·Biochemical Society Transactions·Mi-Kyung YoonRichard W Kriwacki
Oct 17, 2013·The Journal of Biological Chemistry·Sulagna BanerjeeAshok K Saluja
Jun 25, 2014·Oncology Letters·César Rivera, Bernardo Venegas

❮ Previous
Next ❯

Citations

May 11, 2019·Experimental Cell Research·Daniel W ColeAndrew M Fribley
Apr 4, 2017·Gastroenterology·Chang-Kyung KimVincent W Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.